Efatutazone

DB11894InvestigationalSmall molecule

Efatutazone has been used in trials studying the treatment of Lymphoma, Liposarcoma, Solid Tumors, Multiple Myeloma, and Recurrent Thyroid Cancer, among others.

Chemical structure of Efatutazone
Formula / weight
C27H26N4O4S · 502.59 g/mol (avg)

Resolves to

Compound
UNIIM17ILL71MCCAS223132-37-4ChEMBLCHEMBL3545280PubChem9832447
Structure
InChIKeyJCYNMRJCUYVDBC-UHFFFAOYSA-NSMILESCN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=C(OC3=CC(C)=C(N)C(C)=C3)C=C12
Targets
P37231PPARG

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Efatutazone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In